Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Bander

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2016
Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted TherapyAlla G Wernicke, Sae Kim, He Liu, et al.
The Prostate|July 4, 2009
Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacyKenji Kuroda, He Liu, Sae Kim, et al.
The Prostate|July 13, 2010
Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activityKenji Kuroda, He Liu, Sae Kim, et al.
The Prostate|January 13, 2004
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude miceShankar Vallabhajosula, Peter M Smith-Jones, Vincent Navarro, et al.
Biomedical Microdevices|December 7, 2011
Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevicesSteven M Santana, He Liu, Neil H Bander, et al.
Cancer Research|May 17, 2003
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activityGopalakrishnapillai Anilkumar, Sigrid A Rajasekaran, Song Wang, et al.
Oncotargets and Therapy|December 16, 2014
Microtubule inhibitor-based antibody-drug conjugates for cancer therapyKelsey Klute, Eleni Nackos, Shinsuke Tasaki, et al.
Bioconjugate Chemistry|July 12, 2011
Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugateTakahito Nakajima, Makoto Mitsunaga, Neil H Bander, et al.
Bioconjugate Chemistry|November 18, 2004
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapyAnil K Patri, Andrzej Myc, James Beals, et al.
Seminars in Oncology|October 23, 2003
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigenNeil H Bander, David M Nanus, Matthew I Milowsky, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 11, 2016
Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted TherapyAlla G Wernicke, Sae Kim, He Liu, et al.
The Prostate|July 4, 2009
Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacyKenji Kuroda, He Liu, Sae Kim, et al.
The Prostate|July 13, 2010
Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activityKenji Kuroda, He Liu, Sae Kim, et al.
The Prostate|January 13, 2004
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude miceShankar Vallabhajosula, Peter M Smith-Jones, Vincent Navarro, et al.
Biomedical Microdevices|December 7, 2011
Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevicesSteven M Santana, He Liu, Neil H Bander, et al.
Cancer Research|May 17, 2003
Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activityGopalakrishnapillai Anilkumar, Sigrid A Rajasekaran, Song Wang, et al.
Oncotargets and Therapy|December 16, 2014
Microtubule inhibitor-based antibody-drug conjugates for cancer therapyKelsey Klute, Eleni Nackos, Shinsuke Tasaki, et al.
Bioconjugate Chemistry|July 12, 2011
Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugateTakahito Nakajima, Makoto Mitsunaga, Neil H Bander, et al.
Bioconjugate Chemistry|November 18, 2004
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapyAnil K Patri, Andrzej Myc, James Beals, et al.
Seminars in Oncology|October 23, 2003
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigenNeil H Bander, David M Nanus, Matthew I Milowsky, et al.
Pageof 9